docetaxel anhydrous has been researched along with Cancer of Gastrointestinal Tract in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (28.57) | 18.2507 |
| 2000's | 6 (28.57) | 29.6817 |
| 2010's | 7 (33.33) | 24.3611 |
| 2020's | 2 (9.52) | 2.80 |
| Authors | Studies |
|---|---|
| Bai, X; Fang, J; Han, X; Hennink, WE; Jiao, J; Kiessling, F; Lammers, T; Lan, T; Lei, P; Liang, C; Liang, R; Metselaar, JM; Möckel, D; Qi, C; Shi, Y; Storm, G; Sun, Q; Wang, Y; Wei, B; Wei, H; Zhang, H; Zheng, X; Zheng, Z | 1 |
| Amin, M; Baggstrom, M; Belanger, S; Fracasso, PM; Gao, F; Lockhart, AC; Ma, C; Naughton, MJ; Picus, J; Suresh, R; Tan, B; Terrero, G; Trull, L; Wang-Gillam, A | 1 |
| Cervantes, A; Moreno Vera, S; Peeters, M; Taieb, J | 1 |
| Adelstein, DJ; Bokar, JA; Dowlati, A; Fu, P; Halmos, B; Jia, Y; Juergens, R; Rodal, MB | 1 |
| Asari, R; Ba-Ssalamah, A; Birner, P; Hejna, M; Ilhan-Mutlu, A; Pluschnig, U; Preusser, M; Püspök, A; Schoppmann, SF; Schwameis, K; Zacherl, J | 1 |
| Dunn, JA; Ford, HE; Hulme, CT; Marshall, A; Meads, DM | 1 |
| Huang, CQ; Ji, ZH; Li, Y; Peng, KW; Sun, JH; Wu, HT; Yang, XJ; Zhang, Q | 1 |
| Berglund, A; Byström, P; Einarsson, R; Glimelius, B; Johansson, B; Larsson, A; Nygren, P; Wernroth, L | 1 |
| Belkhiri, A; Ecsedy, J; El-Rifai, W; Katsha, A; Sehdev, V; Zaika, A | 1 |
| Mohamed, F; Sugarbaker, PH | 1 |
| Chow, W; Chu, D; Doroshow, JH; Frankel, P; Leong, L; Lim, D; Lin, P; Margolin, K; Morgan, RJ; Paz, B; Schwarz, R; Shibata, S; Somlo, G; Stalter, S; Synold, T; Twardowski, P; Yen, Y | 1 |
| Clark, JW; Fuchs, CS; Kim, H; Kulke, MH; Mayer, RJ; Ryan, DP; Stuart, K; Vincitore, M | 1 |
| Bekaii-Saab, TS; Villalona-Calero, MA | 1 |
| Benson Iii, AB; Loehrer, PJ; Meropol, NJ; Mulcahy, MF; Rademaker, AW | 1 |
| Rougier, P | 1 |
| Ogawa, M | 1 |
| Aapro, MS | 1 |
| Sasaki, T | 1 |
| Armand, JP; Cunningham, D; Kohne, CH; Misset, JL; van Cutsem, E | 1 |
| Adenis, A; Conroy, T; Paillot, B | 1 |
| Kumazaki, T; Matsukawa, M; Nishiyama, M; Okamoto, R; Park, JS; Sasaki, M; Sekikawa, T; Tanimoto, K; Ukon, K; Yamamoto, W | 1 |
8 review(s) available for docetaxel anhydrous and Cancer of Gastrointestinal Tract
| Article | Year |
|---|---|
Trifluridine/tipiracil: an emerging strategy for the management of gastrointestinal cancers.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Camptothecin; Clinical Trials as Topic; Colonic Neoplasms; Docetaxel; Drug Combinations; Fluorouracil; Gastrointestinal Neoplasms; Humans; Immunotherapy; Indoles; Irinotecan; Organoplatinum Compounds; Oxaliplatin; Pyrrolidines; Quality of Life; Taxoids; Thymine; Trifluridine; Uracil | 2018 |
Intraperitoneal taxanes.
Topics: Antineoplastic Agents, Phytogenic; Biological Availability; Chemotherapy, Adjuvant; Clinical Trials, Phase II as Topic; Docetaxel; Dose-Response Relationship, Drug; Female; Gastrointestinal Neoplasms; Humans; Infusions, Parenteral; Male; Maximum Tolerated Dose; Paclitaxel; Risk Assessment; Sensitivity and Specificity; Taxoids | 2003 |
Preclinical experience with docetaxel in gastrointestinal cancers.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Docetaxel; Gastrointestinal Neoplasms; Humans; Taxoids; Tumor Stem Cell Assay; Xenograft Model Antitumor Assays | 2005 |
Docetaxel delivers new management opportunities for gastrointestinal carcinomas.
Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Chemotherapy, Adjuvant; Clinical Trials, Phase II as Topic; Colorectal Neoplasms; Docetaxel; Female; Gastrointestinal Neoplasms; Humans; Male; Middle Aged; Multicenter Studies as Topic; Neoplasm Metastasis; Paclitaxel; Pancreatic Neoplasms; Stomach Neoplasms; Taxoids | 1995 |
New systemic drugs in the treatment of gastrointestinal cancer.
Topics: Antineoplastic Agents, Phytogenic; Camptothecin; Clinical Trials as Topic; Docetaxel; Gastrointestinal Neoplasms; Humans; Irinotecan; Paclitaxel; Quinazolines; Taxoids; Thiophenes; Thymidylate Synthase | 1996 |
[New anti-cancer drugs for gastrointestinal cancers].
Topics: Amino Acids; Antidotes; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Camptothecin; Clinical Trials, Phase II as Topic; Docetaxel; Drug Administration Schedule; Fluorouracil; Gastrointestinal Neoplasms; Humans; Interferons; Irinotecan; Leucovorin; Paclitaxel; Taxoids | 1997 |
Clinical advances with topoisomerase I inhibitors in gastrointestinal malignancies.
Topics: Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Docetaxel; Enzyme Inhibitors; Fluorouracil; Gastrointestinal Neoplasms; Humans; Irinotecan; Organoplatinum Compounds; Oxaliplatin; Paclitaxel; Platinum; Quinazolines; Taxoids; Thiophenes; Topoisomerase I Inhibitors | 1999 |
[New drugs in gastrointestinal oncology. Current status and future directions].
Topics: Antineoplastic Agents; Camptothecin; Capecitabine; Deoxycytidine; Docetaxel; Floxuridine; Fluorouracil; Gastrointestinal Neoplasms; Gemcitabine; Humans; Irinotecan; Organoplatinum Compounds; Oxaliplatin; Paclitaxel; Quinazolines; Taxoids; Tegafur; Thiophenes; Vinblastine; Vinorelbine | 1999 |
7 trial(s) available for docetaxel anhydrous and Cancer of Gastrointestinal Tract
| Article | Year |
|---|---|
Phase I Study of Docetaxel and Temsirolimus in Refractory Solid Tumors.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Drug Resistance, Neoplasm; Female; Gastrointestinal Neoplasms; Humans; Lung Neoplasms; Male; Maximum Tolerated Dose; Middle Aged; Sirolimus; Treatment Outcome | 2021 |
A Phase I study of the combination of oxaliplatin/docetaxel and vandetanib for the treatment of advanced gastroesophageal cancer.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Dose-Response Relationship, Drug; Gastrointestinal Neoplasms; Humans; Male; Maximum Tolerated Dose; Middle Aged; Organoplatinum Compounds; Oxaliplatin; Piperidines; Protein Kinase Inhibitors; Quinazolines; Receptors, Vascular Endothelial Growth Factor; Taxoids | 2013 |
Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy with lobaplatin and docetaxel improves survival for patients with peritoneal carcinomatosis from abdominal and pelvic malignancies.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Chemotherapy, Adjuvant; Chemotherapy, Cancer, Regional Perfusion; Cyclobutanes; Cytoreduction Surgical Procedures; Docetaxel; Drug Synergism; Feasibility Studies; Female; Gastrointestinal Neoplasms; Genital Neoplasms, Female; Humans; Hyperthermia, Induced; Male; Middle Aged; Organoplatinum Compounds; Peritoneal Neoplasms; Survival Rate; Taxoids; Treatment Outcome | 2016 |
An explorative study on the clinical utility of baseline and serial serum tumour marker measurements in advanced upper gastrointestinal cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Pharmacological; Biomarkers, Tumor; Blood Chemical Analysis; Camptothecin; Disease Progression; Docetaxel; Female; Fluorouracil; Gastrointestinal Neoplasms; Humans; Irinotecan; Leucovorin; Male; Middle Aged; Predictive Value of Tests; Prognosis; Taxoids; Upper Gastrointestinal Tract | 2010 |
Phase I trial of intraperitoneal docetaxel in the treatment of advanced malignancies primarily confined to the peritoneal cavity: dose-limiting toxicity and pharmacokinetics.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents, Phytogenic; Docetaxel; Female; Gastrointestinal Neoplasms; Humans; Infusions, Parenteral; Male; Maximum Tolerated Dose; Middle Aged; Ovarian Neoplasms; Peritoneal Neoplasms; Stomach Neoplasms; Taxoids; Treatment Outcome | 2003 |
A phase II study of docetaxel in patients with metastatic carcinoid tumors.
Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinoid Tumor; Disease-Free Survival; Docetaxel; Female; Gastrointestinal Neoplasms; Humans; Hydroxyindoleacetic Acid; Life Tables; Lung Neoplasms; Male; Middle Aged; Octreotide; Radiography; Salvage Therapy; Survival Analysis; Taxoids; Treatment Failure | 2004 |
A phase I study of docetaxel, Cisplatin, 5-Fluorouracil and leucovorin.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Dose-Response Relationship, Drug; Female; Fluorouracil; Gastrointestinal Neoplasms; Humans; Leucovorin; Male; Maximum Tolerated Dose; Middle Aged; Taxoids; Treatment Outcome | 2005 |
6 other study(ies) available for docetaxel anhydrous and Cancer of Gastrointestinal Tract
| Article | Year |
|---|---|
Π electron-stabilized polymeric micelles potentiate docetaxel therapy in advanced-stage gastrointestinal cancer.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Docetaxel; Drug Carriers; Electrons; Gastrointestinal Neoplasms; Mice; Micelles; Polyethylene Glycols; Tumor Microenvironment | 2021 |
Comparison between DCF (Docetaxel, Cisplatin and 5-Fluorouracil) and modified EOX (Epirubicin, Oxaliplatin and Capecitabine) as palliative first-line chemotherapy for adenocarcinoma of the upper gastrointestinal tract.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Cisplatin; Deoxycytidine; Docetaxel; Epirubicin; Female; Fluorouracil; Gastrointestinal Neoplasms; Humans; Male; Middle Aged; Organoplatinum Compounds; Oxaliplatin; Palliative Care; Retrospective Studies; Taxoids; Treatment Outcome; Upper Gastrointestinal Tract | 2013 |
The Cost Effectiveness of Docetaxel and Active Symptom Control versus Active Symptom Control Alone for Refractory Oesophagogastric Adenocarcinoma: Economic Analysis of the COUGAR-02 Trial.
Topics: Adenocarcinoma; Cost-Benefit Analysis; Docetaxel; Esophageal Neoplasms; Gastrointestinal Neoplasms; Health Care Costs; Humans; Quality-Adjusted Life Years; Taxoids | 2016 |
The combination of alisertib, an investigational Aurora kinase A inhibitor, and docetaxel promotes cell death and reduces tumor growth in preclinical cell models of upper gastrointestinal adenocarcinomas.
Topics: Adenocarcinoma; Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Aurora Kinase A; Aurora Kinases; Azepines; Cell Cycle Checkpoints; Cell Survival; Docetaxel; Female; Gastrointestinal Neoplasms; Humans; Mice; Mice, Nude; Polyploidy; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Pyrimidines; Taxoids; Xenograft Model Antitumor Assays | 2013 |
Phase II data on paclitaxel and docetaxel in gastrointestinal malignancies.
Topics: Antineoplastic Agents, Phytogenic; Clinical Trials, Phase II as Topic; Docetaxel; Gastrointestinal Neoplasms; Humans; Paclitaxel; Taxoids | 1996 |
Cellular sensitivity determinants to docetaxel in human gastrointestinal cancers.
Topics: bcl-X Protein; Cell Division; Docetaxel; Ethacrynic Acid; Flow Cytometry; Gastrointestinal Neoplasms; Gene Expression Regulation, Neoplastic; Genes, p53; Glutathione S-Transferase pi; Glutathione Transferase; Humans; Inhibitory Concentration 50; Isoenzymes; Paclitaxel; Proto-Oncogene Proteins c-bcl-2; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Taxoids; Time Factors; Transfection; Tubulin; Tumor Cells, Cultured | 2002 |